246250 — SLS Bio Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapFalling Star

Annual balance sheet for SLS Bio Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	ARS	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	90.8	1,390	2,548	9,355	7,680
Net Total Accounts Receivable
Net Total Receivables	1,722	2,059	3,035	2,057	1,877
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	2,146	3,758	6,058	11,751	9,789
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	5,312	4,790	4,084	4,173	4,740
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	10,135	10,506	11,753	17,838	16,359
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2,984	3,395	2,043	1,736	1,474
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	6,597	6,782	5,048	4,371	3,845
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	3,538	3,724	6,705	13,466	12,513
Total Liabilities & Shareholders' Equity	10,135	10,506	11,753	17,838	16,359
Total Common Shares Outstanding